These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 24995330)

  • 1. Cubic and hexagonal liquid crystals as drug delivery systems.
    Chen Y; Ma P; Gui S
    Biomed Res Int; 2014; 2014():815981. PubMed ID: 24995330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spotlight on Biomimetic Systems Based on Lyotropic Liquid Crystal.
    de Souza JF; Pontes KD; Alves TF; Amaral VA; Rebelo MA; Hausen MA; Chaud MV
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28272377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lyotropic liquid crystals for parenteral drug delivery.
    Chavda VP; Dawre S; Pandya A; Vora LK; Modh DH; Shah V; Dave DJ; Patravale V
    J Control Release; 2022 Sep; 349():533-549. PubMed ID: 35792188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlling molecular transport and sustained drug release in lipid-based liquid crystalline mesophases.
    Zabara A; Mezzenga R
    J Control Release; 2014 Aug; 188():31-43. PubMed ID: 24910192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent patents on nonlamellar liquid crystalline lipid phases in drug delivery.
    Koynova R; Tenchov B
    Recent Pat Drug Deliv Formul; 2013 Dec; 7(3):165-73. PubMed ID: 23829393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bicontinuous cubic liquid crystals as sustained delivery systems for peptides and proteins.
    Rizwan SB; Boyd BJ; Rades T; Hook S
    Expert Opin Drug Deliv; 2010 Oct; 7(10):1133-44. PubMed ID: 20858165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tailoring liquid crystalline lipid nanomaterials for controlled release of macromolecules.
    Bisset NB; Boyd BJ; Dong YD
    Int J Pharm; 2015 Nov; 495(1):241-248. PubMed ID: 26319637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimuli responsive liquid crystals provide 'on-demand' drug delivery in vitro and in vivo.
    Fong WK; Hanley T; Boyd BJ
    J Control Release; 2009 May; 135(3):218-26. PubMed ID: 19331865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin ocular delivery systems based on glycerol monooleate reversed hexagonal and reversed cubic liquid crystalline phases.
    Milak S; Chemelli A; Glatter O; Zimmer A
    Eur J Pharm Biopharm; 2019 Jun; 139():279-290. PubMed ID: 31002864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral and transdermal drug delivery systems: role of lipid-based lyotropic liquid crystals.
    Rajabalaya R; Musa MN; Kifli N; David SR
    Drug Des Devel Ther; 2017; 11():393-406. PubMed ID: 28243062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injectable in situ forming gel based on lyotropic liquid crystal for persistent postoperative analgesia.
    Mei L; Xie Y; Huang Y; Wang B; Chen J; Quan G; Pan X; Liu H; Wang L; Liu X; Wu C
    Acta Biomater; 2018 Feb; 67():99-110. PubMed ID: 29225151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lyotropic liquid crystalline phases: Drug delivery and biomedical applications.
    Chavda VP; Dyawanapelly S; Dawre S; Ferreira-Faria I; Bezbaruah R; Rani Gogoi N; Kolimi P; Dave DJ; Paiva-Santos AC; Vora LK
    Int J Pharm; 2023 Nov; 647():123546. PubMed ID: 37884213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetically-stimulated transformations in nanostructure of lipid mesophases: Effect of structure of iron oxide nanoparticles.
    Sun X; Alcaraz N; Qiao R; Hawley A; Tan A; Boyd BJ
    Colloids Surf B Biointerfaces; 2020 Jul; 191():110965. PubMed ID: 32220812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycerol monooleate liquid crystalline phases used in drug delivery systems.
    Milak S; Zimmer A
    Int J Pharm; 2015 Jan; 478(2):569-87. PubMed ID: 25479099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanostructured cubosomes as advanced drug delivery system.
    Pan X; Han K; Peng X; Yang Z; Qin L; Zhu C; Huang X; Shi X; Dian L; Lu M; Wu C
    Curr Pharm Des; 2013; 19(35):6290-7. PubMed ID: 23470001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oil and drug control the release rate from lyotropic liquid crystals.
    Martiel I; Baumann N; Vallooran JJ; Bergfreund J; Sagalowicz L; Mezzenga R
    J Control Release; 2015 Apr; 204():78-84. PubMed ID: 25744826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advances in the study of lipid-based cubic liquid crystalline nanoparticles as drug delivery system].
    Wu HB; Huo DF; Jiang XG
    Yao Xue Xue Bao; 2008 May; 43(5):450-5. PubMed ID: 18717329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide-sensing actuators for modulating structure in lipid-based liquid crystalline drug delivery systems.
    Liu Q; Hu J; Whittaker MR; Davis TP; Boyd BJ
    J Colloid Interface Sci; 2017 Dec; 508():517-524. PubMed ID: 28866460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid polymorphism in lyotropic liquid crystals for triggered release of bioactives.
    Garti N; Libster D; Aserin A
    Food Funct; 2012 Jul; 3(7):700-13. PubMed ID: 22592749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonlamellar liquid crystalline nanostructured particles: advances in materials and structure determination.
    Boyd BJ; Dong YD; Rades T
    J Liposome Res; 2009; 19(1):12-28. PubMed ID: 19515004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.